| Added by | pcoopman |
|---|---|
| Group name | EquipePC |
| Item Type | Attachment |
| Title | PubMed entry |
| URL | http://www.ncbi.nlm.nih.gov/pubmed/32286687 |
| Accessed | 2020/07/17 - 19:58:24 |
| Date Added | 2020/07/17 - 17:58:24 |
| Date Modified | 2020/07/17 - 17:58:24 |
| Parent item | Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer |
Institut de Recherche en Cancérologie de
